Use of bioresorbable vascular scaffold: a meta-analysis of patients with coronary artery disease.

Open Heart · 2016 · PMC5013412 · PMID 27621831

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendp=0.07so close (0.05 < p ≤ 0.1)

Compared with DES, patients treated with BVS showed a trend towards an increase in the risk of MI (125 events in those assigned to BVS and 50 to DES; OR 1.36; CI 0.97 to 1.91; I 2 =0%; p=0.07) (p=0.06 by fixed-effect model)) ( figure 1 C).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.